Business Model – Revenue Streams
When commercialized, our breakthrough biosystem technologies will:
Help to create a very profitable biomass production platform with the third year 200-unit SM plant net revenue projecting over $15 to $21.5 million in net revenues w/ ROI in 3.5 yrs.
Pave the way for us to build our own 200-unit SM plant with approximately one million gallons in continuous biomass production.
Generate royalty income from the use of our BioStim™ commercialized systems for increasing biomass in third-party biomass and fermentation/ brewing companies.
Net Revenue
ROI
Royalty Income
Cyanotech, a public company in Hawaii, producing astaxanthin but without BioStim™ electromagnetic biostimulation or our SES level of commercial scale Co2 conversion via the environmentally controlled enclosed bioreactor system.